feedback welcome

Psychiatrynet:Background

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
Line 15: Line 15:
* ''' Klaas Kooistra, MSc, PharmD''': moodstabilizers
* ''' Klaas Kooistra, MSc, PharmD''': moodstabilizers
* ''' Ashni Lo-Kim-Lin, BSc, coming up MSc, PharmD''': general
* ''' Ashni Lo-Kim-Lin, BSc, coming up MSc, PharmD''': general
-
* ''' Lenneke Minjon, BSc, coming up MSc, PharmD''': plain stopping antidepressants (in progress)
+
* ''' Lenneke Minjon, BSc, coming up MSc, PharmD''': plain stopping antidepressants
* ''' Alexandra Mulder, MSc, PharmD''': antidepressants
* ''' Alexandra Mulder, MSc, PharmD''': antidepressants
* ''' Verena Mulder, MSc, PharmD''': antipsychotics
* ''' Verena Mulder, MSc, PharmD''': antipsychotics

Revision as of 07:04, 2 August 2011

More information and/or sources of switching antidepressants and antipsychotics

Walter Broekema

He is hospital pharmacist and head of the clinical pharmacy department at GGz Centraal in Amersfoort, The Netherlands. He also has pharmaceutical responsibility for a number of other Mental Health Institutions. He graduated as a pharmacist in 1979 and gained his specialisation `hospital pharmacist' in 1991. He has worked at university and community pharmacy. He is active in several organisations inside and outside the hospital, nationally and internationally. He is president of the Special Interest Group Psychiatry of the Dutch Association of Hospital Pharmacists (NVZA/KNMP). He initiated the ATC-drug-distribution robot, started an early audiovisual quality manual and is active in several E-projects like this one. One of his favourites is multidisciplinary cooperation and education. He actively participates in (inter)national conferences. Conflict of interests: no pharmaceutical companies nor financial interest is involved. Declared 2011.


Acknowledgements


Improvements




Navigation
About